Bayer Strengthens Allergic Rhinitis Care in UAE Through Strategic Alliances with Medical Societies
Bayer has announced major strategic partnerships with the Emirates ENT Society and the Emirates Pharmacists Society to elevate the management of Allergic Rhinitis in the region. The initiative was unveiled during a regional allergy awareness media roundtable in Dubai, ahead of the anticipated launch of ClariSpray, Bayer’s latest nasal spray innovation.
Allergic rhinitis affects up to 45% of the population in the region, with symptoms that significantly reduce quality of life and productivity. Bayer’s latest effort demonstrates its ongoing commitment to enhancing public health through science-backed, patient-centric solutions and collaborative awareness campaigns.
ClariSpray: A New Hope for Allergy Relief
The upcoming launch of ClariSpray marks a new chapter in allergy treatment. Bayer affirms the spray is designed to help individuals manage nasal congestion and other allergic rhinitis symptoms more effectively, empowering them to return to their daily routines with greater ease.
“ClariSpray is a reflection of Bayer’s scientific dedication and mission to improve lives. We believe it will significantly expand the available options for allergy sufferers,” said Dr. Mohammad Galal, Vice President and Head of Middle East & Pakistan at Bayer Consumer Health.
Expert Endorsement for Strategic Healthcare Collaboration
Leaders from the partnering societies welcomed Bayer’s initiative as a model for effective collaboration between the pharmaceutical sector and medical professionals.
Dr. Mohammed Ahmed Abdulla Al Hammadi, Vice President of the Emirates ENT Society, emphasized:
“This partnership harnesses Bayer’s innovation and our clinical expertise to enhance treatment outcomes for allergy patients across the region.”
Dr. Abdulla Al Kindi, Head of the Emirates Pharmacists Society, added:
“Working together will enable us to better respond to patient needs, strengthen pharmacist capabilities, and improve access to personalized allergy care.”
A Holistic Vision for Allergy Management
This multi-stakeholder collaboration aims to:
-
Deepen insights into the region’s allergy challenges
-
Improve access to quality treatment options
-
Enhance public awareness and health literacy
-
Equip healthcare professionals with the tools and knowledge needed to optimize patient care
As allergy season intensifies across the GCC, this strategic alliance is set to become a benchmark for integrated, patient-focused care in the region—one that combines medical leadership, pharmaceutical innovation, and community education.
